The data for 2024 shows varied mortality rates for Nervous System Diseases across countries, expressed in deaths per 100,000 persons. Finland stands at the highest rate, while Bulgaria shows the lowest. Recent trends reveal significant increases in countries like Colombia and the United States, whereas others like South Africa and Spain see declines. The five-year CAGR indicates moderate changes with notable increments in Slovenia and the Czech Republic.
Future trends to watch include the impact of healthcare advancements and lifestyle changes. Countries like Finland may implement strategies to address high mortality rates, while others see ongoing research as pivotal to understanding these diseases better and lowering mortality rates.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Deaths) Per Hundred Thousand Persons, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Finland | 148.7 | 2023 | +1.36% | +1.3% | View data |
| 2 | 2 Iceland | 94.5 | 2023 | +4.77% | -0.042% | View data |
| 3 | 3 United States | 90 | 2023 | +3.33% | +4.51% | View data |
| 4 | 4 United Kingdom | 65.5 | 2023 | +3.64% | +3.48% | View data |
| 5 | 5 Australia | 43.7 | 2023 | +1.86% | +2.35% | View data |
| 6 | 6 Slovenia | 42 | 2023 | +5.26% | +7.69% | View data |
| 7 | 7 Netherlands | 41.9 | 2023 | +0.96% | -1.42% | View data |
| 8 | 8 Spain | 38.2 | 2023 | -1.8% | -1.74% | View data |
| 9 | 9 Canada | 37.1 | 2023 | -0.27% | -0.48% | View data |
| 10 | 10 Czech Republic | 36.2 | 2023 | +1.69% | +1.81% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
